Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences
Go back to Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences| Danaher Corp. (NYSE: DHR) | Delayed: 178.19 +1.02 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $177.17 | 52 Week High | $102.79 | |||
| Open | $176.44 | 52 Week Low | $75.71 | |||
| Day High | $179.30 | P/E | 46.89 | |||
| Day Low | $175.00 | EPS | $3.80 | |||
| Volume | 3,691,894 | |||||
| General Electric (NYSE: GE) | Delayed: 355.12 -2.52 (0.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $357.64 | 52 Week High | $33.00 | |||
| Open | $357.64 | 52 Week Low | $27.10 | |||
| Day High | $361.28 | P/E | 241.58 | |||
| Day Low | $354.54 | EPS | $1.47 | |||
| Volume | 5,426,713 | |||||
